vs

Side-by-side financial comparison of AMREP CORP. (AXR) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

IRIDEX CORP is the larger business by last-quarter revenue ($14.7M vs $14.6M, roughly 1.0× AMREP CORP.). On growth, AMREP CORP. posted the faster year-over-year revenue change (93.8% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs -13.6%).

AMREP Corporation is a real estate and media services company based in Princeton, New Jersey, in the United States. It was founded in 1961 as The American Realty and Petroleum Corporation.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

AXR vs IRIX — Head-to-Head

Bigger by revenue
IRIX
IRIX
1.0× larger
IRIX
$14.7M
$14.6M
AXR
Growing faster (revenue YoY)
AXR
AXR
+163.5% gap
AXR
93.8%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
-13.6%
AXR

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
AXR
AXR
IRIX
IRIX
Revenue
$14.6M
$14.7M
Net Profit
$3.1M
Gross Margin
37.2%
Operating Margin
20.6%
Net Margin
21.6%
Revenue YoY
93.8%
-69.7%
Net Profit YoY
338.9%
EPS (diluted)
$0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXR
AXR
IRIX
IRIX
Q1 26
$14.6M
Q4 25
$9.4M
$14.7M
Q3 25
$17.9M
$12.5M
Q2 25
$11.2M
$13.6M
Q1 25
$7.5M
$11.9M
Q4 24
$11.9M
$12.7M
Q3 24
$19.1M
$11.6M
Q2 24
$19.5M
$12.6M
Net Profit
AXR
AXR
IRIX
IRIX
Q1 26
$3.1M
Q4 25
$1.2M
Q3 25
$4.7M
$-1.6M
Q2 25
$3.9M
$-994.0K
Q1 25
$717.0K
$-1.7M
Q4 24
$4.0M
$-834.0K
Q3 24
$4.1M
$-1.9M
Q2 24
$4.1M
$-2.7M
Gross Margin
AXR
AXR
IRIX
IRIX
Q1 26
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Operating Margin
AXR
AXR
IRIX
IRIX
Q1 26
20.6%
Q4 25
11.9%
Q3 25
34.4%
-11.3%
Q2 25
31.7%
-6.9%
Q1 25
5.7%
-1.7%
Q4 24
26.4%
-3.9%
Q3 24
26.1%
-16.1%
Q2 24
23.9%
-20.9%
Net Margin
AXR
AXR
IRIX
IRIX
Q1 26
21.6%
Q4 25
12.8%
Q3 25
26.3%
-12.6%
Q2 25
34.8%
-7.3%
Q1 25
9.5%
-14.2%
Q4 24
33.9%
-6.6%
Q3 24
21.3%
-16.7%
Q2 24
21.2%
-21.2%
EPS (diluted)
AXR
AXR
IRIX
IRIX
Q1 26
$0.58
Q4 25
$0.22
Q3 25
$0.87
$-0.09
Q2 25
$0.73
$-0.06
Q1 25
$0.13
$-0.10
Q4 24
$0.75
$-0.05
Q3 24
$0.76
$-0.12
Q2 24
$0.77
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXR
AXR
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$50.0M
$6.0M
Total DebtLower is stronger
$21.0K
Stockholders' EquityBook value
$139.4M
Total Assets
$143.9M
$29.2M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXR
AXR
IRIX
IRIX
Q1 26
$50.0M
Q4 25
$44.6M
$6.0M
Q3 25
$48.9M
$5.6M
Q2 25
$39.5M
$6.8M
Q1 25
$36.9M
$7.2M
Q4 24
$40.1M
$2.4M
Q3 24
$40.4M
$3.9M
Q2 24
$29.7M
$4.1M
Total Debt
AXR
AXR
IRIX
IRIX
Q1 26
$21.0K
Q4 25
$23.0K
Q3 25
$25.0K
Q2 25
$26.0K
Q1 25
$29.0K
Q4 24
$32.0K
$1.0M
Q3 24
$34.0K
$1.4M
Q2 24
$35.0K
Stockholders' Equity
AXR
AXR
IRIX
IRIX
Q1 26
$139.4M
Q4 25
$136.0M
Q3 25
$134.7M
$4.7M
Q2 25
$130.0M
$6.1M
Q1 25
$126.0M
$852.0K
Q4 24
$125.1M
$2.1M
Q3 24
$122.2M
$2.6M
Q2 24
$118.0M
$4.2M
Total Assets
AXR
AXR
IRIX
IRIX
Q1 26
$143.9M
Q4 25
$140.1M
$29.2M
Q3 25
$140.7M
$28.4M
Q2 25
$133.8M
$31.6M
Q1 25
$128.9M
$34.2M
Q4 24
$129.1M
$29.1M
Q3 24
$127.0M
$30.2M
Q2 24
$122.8M
$31.2M
Debt / Equity
AXR
AXR
IRIX
IRIX
Q1 26
0.00×
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
0.48×
Q3 24
0.00×
0.53×
Q2 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXR
AXR
IRIX
IRIX
Operating Cash FlowLast quarter
$5.4M
Free Cash FlowOCF − Capex
$5.4M
FCF MarginFCF / Revenue
37.0%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
1.72×
TTM Free Cash FlowTrailing 4 quarters
$20.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXR
AXR
IRIX
IRIX
Q1 26
$5.4M
Q4 25
$-4.3M
Q3 25
$9.5M
$-1.2M
Q2 25
$10.2M
$-397.0K
Q1 25
$-3.2M
$-1.1M
Q4 24
$-182.0K
$-1.2M
Q3 24
$10.7M
$-3.1M
Q2 24
$10.7M
$-1.3M
Free Cash Flow
AXR
AXR
IRIX
IRIX
Q1 26
$5.4M
Q4 25
$-4.3M
Q3 25
$9.5M
$-1.2M
Q2 25
$9.7M
$-410.0K
Q1 25
$-3.3M
$-1.2M
Q4 24
$-268.0K
$-1.2M
Q3 24
$10.7M
$-3.1M
Q2 24
$10.3M
FCF Margin
AXR
AXR
IRIX
IRIX
Q1 26
37.0%
Q4 25
-45.9%
Q3 25
53.2%
-9.4%
Q2 25
86.4%
-3.0%
Q1 25
-43.4%
-9.8%
Q4 24
-2.3%
-9.8%
Q3 24
55.8%
-26.5%
Q2 24
52.5%
Capex Intensity
AXR
AXR
IRIX
IRIX
Q1 26
0.1%
Q4 25
0.6%
Q3 25
0.1%
0.1%
Q2 25
5.2%
0.1%
Q1 25
0.3%
0.1%
Q4 24
0.7%
0.1%
Q3 24
0.2%
0.0%
Q2 24
2.3%
0.0%
Cash Conversion
AXR
AXR
IRIX
IRIX
Q1 26
1.72×
Q4 25
-3.54×
Q3 25
2.03×
Q2 25
2.63×
Q1 25
-4.51×
Q4 24
-0.05×
Q3 24
2.63×
Q2 24
2.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons